BioGend Therapeutics Co., Ltd. reported earnings results for the first quarter ended March 31, 2024. For the first quarter, the company reported sales was TWD 35.55 million compared to TWD 10.82 million a year ago. Net loss was TWD 10.96 million compared to TWD 51.23 million a year ago.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
36.7 TWD | -0.81% | +0.55% | -4.05% |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-4.05% | 140M | |
+48.64% | 56.65B | |
-6.44% | 39.44B | |
+40.77% | 39.03B | |
-11.17% | 26.86B | |
+14.28% | 26.75B | |
-21.40% | 19.03B | |
+0.96% | 12.28B | |
+25.64% | 12.26B | |
+27.04% | 12.04B |
- Stock Market
- Equities
- 6733 Stock
- News BioGend Therapeutics Co., Ltd.
- BioGend Therapeutics Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024